Header

Future Science Group Catalogue 2021

1 Section Header

2 For more information visit www.future-science-group.com Contents

Page

Our Journal Portfolio 2 ......

Future Medicine At-A-Glance 3 ......

Future Science and Newlands Press At-A-Glance 4 ...... eBook Collections 4 ......

New to Future Science Group 5 ......

Information for Librarians 6 ......

Institutional Trials 7 ......

Digital Hubs 8 ......

Sponsorship Opportunities 9 ......

Testimonials 9 ......

1 Our Journal Portfolio Our Journal Portfolio

Future Science Group (FSG) is an independent publisher, based in London, with an expanding and diverse group of journals in cutting-edge areas of postgenomic scientific and medical information. FSG houses three imprints; Future Medicine, Future Science and Newlands Press. All journals are peer reviewed and many are also indexed on MEDLINE, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, EMBASE, Chemical Abstracts, DOAJ, PubMed Central and . We also offer DRM-free perpetual access to a wide variety of eBook collections.

ALL PUBLICATIONS ARE:

ORIGINAL AND TIMELY Blending commissioned and unsolicited content, including reviews, research and commentaries, to ensure that readers are kept comprehensively up-to-date with the latest advances and techniques in bioscience and clinical practice, whatever their discipline.

SUPPORTED BY STRONG EDITORIAL STANDARDS

All journals are underpinned by robust double-blind ensuring only articles of the highest quality are published. Authors benefit from a supportive in-house editorial team, taking them from pre-submission enquiries, right through to publication and beyond.

VISIBLE AND ACCESSIBLE GLOBALLY

To ensure 24/7 access and maximum discoverability, all of our titles are hosted by Atypon on industry-leading websites.

2 For more information visit www.future-science-group.com Future Medicine At-A-Glance

FUTURE MEDICINE AT-A-GLANCE

Journal MEDLINE- Frequency Launch indexed (2018) year Bioelectronics in Medicine No n/a 4 2018

Biomarkers in Medicine Yes 2.268 18 2007

Breast Cancer Management No n/a Rolling 2012

CNS Oncology Yes n/a Rolling 2012

Colorectal Cancer No n/a Rolling 2012

Concussion PMC-indexed n/a Rolling 2015

Epigenomics Yes 4.404 24 2009

Future Cardiology Yes n/a 6 2005

Future Microbiology Yes 2.746 18 2006

Future Neurology No n/a Rolling 2006

Future Oncology Yes 2.279 36 2005

Future Virology No 0.730 12 2006

Hepatic Oncology PMC-indexed n/a Rolling 2014

Immunotherapy Yes 3.028 18 2009

International Journal of Endocrine Oncology No n/a Rolling 2014

International Journal of Hematologic Oncology PMC-indexed n/a Rolling 2012

Journal of 3D Printing in Medicine No n/a 4 2017

Journal of Comparative Effectiveness Research Yes 1.485 18 2012

Lung Cancer Management PMC-indexed n/a Rolling 2012

Melanoma Management PMC-indexed n/a Rolling 2014

Nanomedicine Yes 4.717 30 2006

Neurodegenerative Disease Management Yes n/a 6 2011

Pain Management Yes n/a 6 2011

Personalized Medicine Yes 1.414 6 2004

Pharmacogenomics Yes 2.265 18 2000

Regenerative Medicine Yes 2.383 12 2006

: ; PMC: PubMed Central.

3 SectionFuture Science Header and Newlands Press At-A-GlanceFuture Science

FUTURE SCIENCE AND NEWLANDS PRESS AT-A-GLANCE

Journal MEDLINE- Impact factor Frequency Launch indexed (2018) year Bioanalysis Yes 2.321 24 2009

BioTechniques Yes 1.659 12 1983

Future Drug Discovery No n/a Quarterly 2019

Future Medicinal Chemistry Yes 3.617 24 2009

Future Science OA PMC-indexed n/a Rolling 2015

International Journal of Pharmacokinetics No n/a 4 2016

Pharmaceutical Patent Analyst Yes n/a 6 2012

Therapeutic Delivery Yes n/a 12 2010

: Open access; PMC: PubMed Central.

EBOOK COLLECTIONS We offer DRM-free perpetual access to a wide variety of eBook collections.

55 35 15 ONCOLOGY NEUROLOGY BIOMEDICINE

31 153 51 IMMUNOLOGY 15 CLINICAL DRUG R&D & INFECTIOUS CARDIOLOGY MEDICINE DISEASE

4 For more information visit www.future-science-group.com New to Future Science Group

VIDEO JOURNAL OF BIOMEDICINE

The Video Journal of Biomedicine provides readers with short, high-quality, interview- style videos with authors of recently published, peer-reviewed papers. All videos are professionally filmed and produced by our in-house team and published open access on a dedicated platform. Each video provides the opportunity for authors to personally discuss their latest published work in more detail; highlighting its importance to the field, placing it in context, and discussing future implications.

More information is available at: www.biomedicine.video

PHARMAPLATFORMS

armaPlatforms

PUBLISH ENRICH REACH ENGAGE

PharmaPlatforms is the creative arm of FSG, building comprehensive, collaborative communication plans around published content and scientific information. By providing a range of platforms and solutions, we enable timely and accessible publication that enriches the information presented, engages the reader, and reaches a broad, scientific and medical professional audience.

Find out more at: www.pharmaplatforms.com

5 Information for Librarians

INSTITUTIONAL & ACADEMIC SUBSCRIPTIONS Academic pricing is set regardless of size or number of sites. All academic institutions receive 5 years of content. For a quote, contact [email protected].

CORPORATE Corporate pricing is set depending on the size of the company and the number of sites. Corporate institutions receive 2 years of content (backfiles of content are available on request).

CONSORTIA FSG works with consortia of various types and sizes, and welcomes discussion with all consortium managers. COUNTER-compliant usage statistics are provided for each institution. The benefits for the consortium include discounts on list price. Members have the flexibility to select the publications they want to include, or FSG will work with the consortium to create customized packages.

INDEXING FSG titles are abstracted and indexed in all the main databases including MEDLINE/ Index Medicus, EMBASE/Excerpta Medica, Scopus, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, DOAJ, PubMed Central and Chemical Abstracts.

6 For more information visit www.future-science-group.com Institutional Trials Institutional Trials

INSTITUTIONAL TRIALS

If you would like to trial our content, simply get in touch at: [email protected].

Trials can be to single publications or entire collections; the choice is yours. We will work with you to decide on the best time and duration for your institution.

DURING THE PERIOD, YOU HAVE: • Full-text access to the titles you select • Detailed usage statistics from our Atypon-backed platform • Support from our in-house technical team • Control over the duration, visibility and promotion of the trial Fair usage limits apply. For more details, contact [email protected]

SERVICES • Flexible purchasing • Accessible for all institution types • COUNTER-compliant usage reports • ATHENS & Shibboleth authentication compliant • Reliable publishing platform • Dynamic customer services • Promotion tools on request • Collection leasing

7 Digital Hubs

DIGITAL HUBS In addition to our journal content, FSG publishes nine digital hubs, which enable professionals to easily connect and collaborate with their peers in niche scientific fields. Enriched with high-value expert insight and integration with social media, our hubs provide a route to further broadcast content published in our associated publications.

3DMedNet Neuro Central Covering 3D printing and bioprinting in Uniting all aspects of neurology and medicine and healthcare neuroscience www.3dmednet.com www.neuro-central.com

Bioanalysis Zone Oncology Central Market-leading online resource for the global bioanalytical community Delivering the latest news and insights in the fast-moving field of oncology www.bioanalysis-zone.com www.oncology-central.com

BioTechniques The latest methods, techniques and protocols for the life science research RegMedNet community The latest research on all regenerative www.biotechniques.com medicine topics from stem cells to regenerative pharmaceuticals e Evidencewww.regmednet.com The Evidence Base BaseTM Covering the latest news, opinion and insight into the collection and application of real-world data to real-world problems RxNet www.evidencebaseonline.com Uniting scientists from the fieldsNet of chemistry, biochemistry and beyond to further the ever-booming industry Infectious Diseases Hub of drug discovery and development Covering all aspects of medical www.rx-network.com microbiology, from bench to bedside www.id-hub.com

8 For more information visit www.future-science-group.com Sponsorship Opportunities Header and Testimonials

SPONSORSHIP OPPORTUNITIES

Each of our digital hubs offers a variety of sponsorship opportunities, which include:

• Expert interviews and reviews • Infographics • Online symposia • Spotlights • Surveys and polls • Video production • Webinars

TESTIMONIALS

“Bioanalysis Zone is doing an excellent “Regarding the webinar service to the scientific community by process, it was very organizing/hosting webinars on straightforward and painless. interesting and useful topics” I appreciated all the guidance and information you were able – Alliance Pharma to provide us beforehand. It was also great that you were flexible to other options (us providing a recorded presentation). The webinar “It has been a pleasure working with seems to have launched in a Bioanalysis. A publication is only as good timely, smooth manner” as its interface to the readers and contributors. Let me tell you that you – Thermo Fisher Scientific are superior in that respect!”

- Boehringer Ingelheim

9 CONTACT US

Future Science Group Unitec House 2 Albert Place London, N3 1QB United Kingdom

www.future-science-group.com

+44 (0)20 8371 6090

[email protected]

Subscriptions: [email protected]

BioTechniques Support: [email protected]

Institutional Trials: [email protected]

Sales & Advertising: [email protected]

SOCIAL MEDIA

Future Science Group

@futuresciencegp

future-science-group

10 For more information visit www.future-science-group.com